Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Partillion Bioscience has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Partillion Bioscience's investors include National Science Foundation, Paladin Capital Group, Vertical Venture Partners, +ND Capital, National Institutes of Health.
Partillion Bioscience is headquartered in Los Angeles, United States.
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Partillion Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Partillion Bioscience — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/partillion-bioscience. Accessed October 16, 2026.
VCBacked. (2026). Partillion Bioscience — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/partillion-bioscience
{{cite web |title=Partillion Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/partillion-bioscience |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated